Milestone Pharmaceuticals Inc expected to post a loss of 16 cents a share - Earnings Preview

Milestone Pharmaceuticals

08/11/2024 15:32

* Milestone Pharmaceuticals Inc  MIST.OQ   MIST.O  is
expected
to show no change in quarterly revenue when it reports 
results on November 11 (estimated) for the period ending
September 30 2024
    * 
    * ​LSEG's mean analyst estimate for Milestone
Pharmaceuticals Inc
is for a loss of 16 cents per share. 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."  
    * The mean earnings estimate of analysts was unchanged in
the last
three months. ​
    * Wall Street's median 12-month price target for Milestone
Pharmaceuticals Inc is 7.00​, above​ its last closing price
of $1.95. ​​​

Previous quarterly performance (using preferred earnings measure
in US dollars). ​
 QUARTER       STARMINESM  LSEG IBES  ACTUAL    BEAT,   SURPRI
 ENDING        ARTESTIMAT  ESTIMATE             MET,    SE %
               E®                               MISSED  
 Jan. 1 0001   -0.19       -0.19      -0.14     Beat    26.3
 Mar. 31 0001  -0.25                  -0.21             19.2
 Jan. 1 0001   -0.30                  -0.32             -2.4​
 Sep. 30 2023  -0.38       -0.39      -0.35     Beat    8.4
 ​​Jun.        -0.38       -0.39      -0.37     Beat    4.1
 30 2023                                                
 Jan. 1 0001   -0.40       -0.40      -0.35     Beat    12.1​
 Jan. 1 0001               -0.33      -0.31     Beat    7.5
 Jan. 1 0001               -0.41      -0.34     Beat    16.7
 This summary was machine generated November 8 at 15:31 GMT.  All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)